Nanomedicine News

RSS

New Report on the Nanopharmaceutical Market

Do you want to find sales potentials of nanomedicine? If so, our new analysis gives you revenue forecasts to 2025 at overall world market, application, product and national level. That way you discover financial data, trends, R&D, opportunities and commercial outlooks.

3 Nov 2015

Tuskegee University Awarded $1.1 Million Grant to Study Nanoparticle-Based 3-in-1-Platform Technology to Target Cancer

The National Institutes of Health reports that of the estimated 1,658,370 new cases of cancer that will be diagnosed this year, nearly half of those people will lose their battle against the disease.

3 Nov 2015

Researchers Develop Nanoscale DNA Machines That Could Walk Autonomously

Researchers at The University of Texas at Austin have developed a nanoscale machine made of DNA that can randomly walk in any direction across bumpy surfaces. Future applications of such a DNA walker might include a cancer detector that could roam the human body searching for cancerous cells and tagging them for medical imaging or drug targeting.

3 Nov 2015

Superparamagnetic Dextran Iron Oxide Nanoworms Could Escape the Immune System

Iron nanoparticles injected before magnetic resonance imaging can make tissues more visible and the same nanoparticles may allow doctors to precisely target tumors with new medicines.

3 Nov 2015

Portable Lab-in-a-Briefcase Could Help Boost Cancer Detection in Developing Countries

Academics at Loughborough University hope to boost early detection rates of cancer in developing countries with their portable lab-in-a-briefcase that can operate even at high temperatures.

2 Nov 2015

Cancer Drug-Packed ‘Grenades’ Armed with Heat Sensitive Triggers Enable Targeted Treatment of Tumours

Researchers have developed cancer drug-packed ‘grenades’ armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours, according to two studies due to be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

31 Oct 2015

ProNAi Commences Enrollment in 'Brighton' PNT2258 Phase II Trial for Richter's Transformation

ProNAi Therapeutics, Inc., a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced it has enrolled the first patient into the "Brighton" study, a Phase 2 clinical trial evaluating PNT2258 in patients with Richter's transformation.

31 Oct 2015

New Strategy Provides Cancer Imaging with a Single-Agent Theranostic Nanoplatform

Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.

30 Oct 2015

Celator to Present Data on CombiPlex Technology Platform Applied to MTA Drug Combinations at AACR-NCI-EORTC 2015

Celator Pharmaceuticals, Inc. today announced that data from applying the CombiPlex® technology platform to drug combinations incorporating molecularly targeted agents (MTAs) will be presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held in Boston, MA on November 5-9, 2015.

30 Oct 2015

Ultragenyx and Arcturus Partner to Develop mRNA Therapeutics for Rare Diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus’ UNA Oligomer™ chemistry and LUNAR™ nanoparticle delivery platform.

30 Oct 2015

Nanomedicine News

New Report on the Nanopharmaceutical Market

Tuskegee University Awarded $1.1 Million Grant to Study Nanoparticle-Based 3-in-1-Platform Technology to Target Cancer

Researchers Develop Nanoscale DNA Machines That Could Walk Autonomously

Superparamagnetic Dextran Iron Oxide Nanoworms Could Escape the Immune System

Portable Lab-in-a-Briefcase Could Help Boost Cancer Detection in Developing Countries

Cancer Drug-Packed ‘Grenades’ Armed with Heat Sensitive Triggers Enable Targeted Treatment of Tumours

ProNAi Commences Enrollment in 'Brighton' PNT2258 Phase II Trial for Richter's Transformation

New Strategy Provides Cancer Imaging with a Single-Agent Theranostic Nanoplatform

Celator to Present Data on CombiPlex Technology Platform Applied to MTA Drug Combinations at AACR-NCI-EORTC 2015

Ultragenyx and Arcturus Partner to Develop mRNA Therapeutics for Rare Diseases

Nanopore-Based Sensor Enables Rapid and Precise Disease Diagnosis

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Brain-Inspired Nano-Tech Promises New Era for Electronics

Conversations on AFM: Applications of BioAFM in Life Science

Conversations on AFM: The Technology and History Behind AFM and SPM

Recent Advances in High-Speed Atomic Force Microscopy to Improve Research Into Protein Dynamics

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials